首页> 外国专利> 1.8f enhanced prostate (PSMA) membrane antitoxic agent and its inhibitor for image diagnosis of prostate cancer

1.8f enhanced prostate (PSMA) membrane antitoxic agent and its inhibitor for image diagnosis of prostate cancer

机译:1.8f增强型前列腺(PSMA)膜抗毒剂及其抑制剂,用于前列腺癌的图像诊断

摘要

This refers to formula compound (I),Among them: I, j is 0 or 1; m is 1-5; n is 0-3; R is h, CH3; as is natural or artificial amino acid; Z is - CO2H, so2h, SO3H, etc.; X is naftil, phenyl, biphenyl, etc.; arilo, rental, cyclopentyl glycol, etc.; these compounds are used in the field of radio weapons, nuclear medicine, as a marker, in this case, As an image diagnostic agent in different stages of prostate cancer. It also refers to a pharmacological synthesis, the appearance of these compounds, salts or esters, and a pharmaceutically acceptable carrier.
机译:这是指式化合物(I),其中:I,j为0或1; m为1-5; n为0-3; R为h,CH 3;天然或人工氨基酸; Z为-CO2H,so2h,SO3H等; X为萘基,苯基,联苯等; arilo,出租,环戊二醇等;这些化合物在放射性武器,核医学领域用作标记,在这种情况下,作为前列腺癌不同阶段的图像诊断剂。它还指药理合成,这些化合物,盐或酯的外观以及药学上可接受的载体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号